{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:33:09Z","timestamp":1795030389187,"version":"4.10.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-025-06526-0","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:24:43Z","timestamp":1765527883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A prospective, open-label, clinical investigation of a single intra-articular polyacrylamide hydrogel injection in participants with knee osteoarthritis: a 5-year extension study"],"prefix":"10.1186","volume":"21","author":[{"given":"Henning","family":"Bliddal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hartkopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannie","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Conaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"10472","key":"6526_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0140-6736(24)02322-5","volume":"405","author":"M Kloppenburg","year":"2025","unstructured":"Kloppenburg M, Namane M, Cicuttini F. Osteoarthritis. Lancet. 2025;405(10472):71\u201385. https:\/\/doi.org\/10.1016\/S0140-6736(24)02322-5.","journal-title":"Lancet"},{"issue":"6","key":"6526_CR2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jama.2020.22171","volume":"325","author":"JN Katz","year":"2021","unstructured":"Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325(6):568\u201378.","journal-title":"JAMA"},{"issue":"5","key":"6526_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.joca.2015.03.002","volume":"23","author":"VB Kraus","year":"2015","unstructured":"Kraus VB. OARSI clinical trials recommendations: soluble biomarker assessments in clinical trials in osteoarthritis. Osteoarthritis Cartilage. 2015;23(5):686\u201397. https:\/\/doi.org\/10.1016\/j.joca.2015.03.002.","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"6526_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/art.42089","volume":"74","author":"H Long","year":"2022","unstructured":"Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022;74(7):1172\u201383. https:\/\/doi.org\/10.1002\/art.42089.","journal-title":"Arthritis Rheumatol"},{"key":"6526_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMcp1903768","volume":"384","author":"L Sharma","year":"2021","unstructured":"Sharma L. Osteoarthritis of the knee. N Engl J Med. 2021;384:51\u20139.","journal-title":"N Engl J Med"},{"issue":"11","key":"6526_CR6","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578\u201389. https:\/\/doi.org\/10.1016\/j.joca.2019.06.011.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"6526_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/acr.24131","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2020;72(2):149\u201362.","journal-title":"Arthritis Care Res"},{"key":"6526_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ph17111557","author":"F Migliorini","year":"2024","unstructured":"Migliorini F, Maffulli N, Schafer L, Kubach J, Betsch M, Pasurka M. Less pain with intra-articular hyaluronic acid injections for knee osteoarthritis compared to placebo: a systematic review and meta-analysis of randomised controlled trials. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17111557.","journal-title":"Pharmaceuticals (Basel)"},{"key":"6526_CR9","unstructured":"Excellence NIfHaC. Osteoarthritis in over 16s: diagnosis and management. NICE Guideline, No 226. National Institute for Health and Care Excellence: Guidelines. London2022."},{"issue":"19","key":"6526_CR10","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.2017.5283","volume":"317","author":"TE McAlindon","year":"2017","unstructured":"McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967\u201375.","journal-title":"JAMA"},{"issue":"1","key":"6526_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13018-023-03637-4","volume":"18","author":"YM Kim","year":"2023","unstructured":"Kim YM, Joo YB, Song JH. Preoperative intra-articular steroid injections within 3 months increase the risk of periprosthetic joint infection in total knee arthroplasty: a systematic review and meta-analysis. J Orthop Surg Res. 2023;18(1):148.","journal-title":"J Orthop Surg Res"},{"issue":"6","key":"6526_CR12","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/PRS.0b013e3181d18158","volume":"125","author":"N Pallua","year":"2010","unstructured":"Pallua N, Wolter TP. A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients. Plast Reconstr Surg. 2010;125(6):1797\u2013804. https:\/\/doi.org\/10.1097\/PRS.0b013e3181d18158.","journal-title":"Plast Reconstr Surg"},{"key":"6526_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24589","author":"T Brosche","year":"2021","unstructured":"Brosche T, Kuhn A, Lobodasch K, Sokol ER. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 2021. https:\/\/doi.org\/10.1002\/nau.24589.","journal-title":"Neurourol Urodyn"},{"issue":"02","key":"6526_CR14","first-page":"1188","volume":"6","author":"H Bliddal","year":"2021","unstructured":"Bliddal H, Overgaard A, Hartkopp A, Beier J, Conaghan PG, Henriksen M. Polyacrylamide hydrogel injection for knee osteoarthritis: a 6 months prospective study. J Orthop Res Ther. 2021;6(02):1188.","journal-title":"J Orthop Res Ther"},{"issue":"1","key":"6526_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13018-024-04756-2","volume":"19","author":"H Bliddal","year":"2024","unstructured":"Bliddal H, Beier J, Hartkopp A, Conaghan PG, Henriksen M. Effectiveness and safety of polyacrylamide hydrogel injection for knee osteoarthritis: results from a 12-month follow up of an open-label study. J Orthop Surg Res. 2024;19(1):274.","journal-title":"J Orthop Surg Res"},{"issue":"6","key":"6526_CR16","first-page":"1082","volume":"36","author":"M Henriksen","year":"2018","unstructured":"Henriksen M, Overgaard A, Hartkopp A, Bliddal H. Intra-articular 2.5% polyacrylamide hydrogel for the treatment of knee osteoarthritis: an observational proof-of-concept cohort study. Clin Exp Rheumatol. 2018;36(6):1082\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"6526_CR17","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.55563\/clinexprheumatol\/i3fqee","volume":"42","author":"H Bliddal","year":"2024","unstructured":"Bliddal H, Beier J, Hartkopp A, Conaghan PG, Henriksen M. Polyacrylamide gel versus hyaluronic acid for the treatment of knee osteoarthritis: a randomised controlled study. Clin Exp Rheumatol. 2024;42(9):1729\u201335. https:\/\/doi.org\/10.55563\/clinexprheumatol\/i3fqee.","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"6526_CR18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039\u201349.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"6526_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494\u2013502. https:\/\/doi.org\/10.1136\/ard.16.4.494.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"6526_CR20","first-page":"1833","volume":"15","author":"N Bellamy","year":"1988","unstructured":"Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833\u201340.","journal-title":"J Rheumatol"},{"issue":"Supplement\u202f1","key":"6526_CR21","first-page":"S372","volume":"30","author":"H Bliddal","year":"2022","unstructured":"Bliddal H, Beier J, Hartkopp A, Conaghan PG, Henriksen M. A prospective study of polyacrylamide hydrogel for knee osteoarthritis: results from 2 years after treatment. Osteoarthritis Cartilage. 2022;30(Supplement\u202f1):S372","journal-title":"Osteoarthritis Cartilage"},{"issue":"5","key":"6526_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.joca.2023.02.023","volume":"31","author":"M Henriksen","year":"2023","unstructured":"Henriksen\u202fM, Beier\u202fJ, Hartkopp\u202fA, Conaghan\u202fPG, Bliddal\u202fH. A prospective study of polyacrylamide hydrogel for knee osteoarthritis: 3\u202fyear results from a prospective study of polyacrylamide hydrogel for knee osteoarthritis. Osteoarthritis Cartilage. 2023;31(5):682\u2013683.","journal-title":"Osteoarthritis Cartilage"},{"issue":"8","key":"6526_CR23","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s40279-025-02265-8","volume":"55","author":"F Migliorini","year":"2025","unstructured":"Migliorini F, Maffulli N, Simeone F, Jeyaraman N, Ramasubramanian S, Jeyaraman M. Intra-articular hyaluronic acid injections may be beneficial in patients with less advanced knee osteoarthritis: a systematic review of randomised controlled trials. Sports Med. 2025;55(8):1953\u201369.","journal-title":"Sports Med"},{"issue":"7","key":"6526_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/acr.22538","volume":"67","author":"N Bellamy","year":"2015","unstructured":"Bellamy N, Hochberg M, Tubach F, Martin-Mola E, Awada H, Bombardier C, et al. Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis. Arthritis Care Res. 2015;67(7):972\u201380.","journal-title":"Arthritis Care Res"},{"issue":"11","key":"6526_CR25","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.joca.2016.07.007","volume":"24","author":"L Christensen","year":"2016","unstructured":"Christensen L, Camitz L, Illigen KE, Hansen M, Sarvaa R, Conaghan PG. Synovial incorporation of polyacrylamide hydrogel after injection into normal and osteoarthritic animal joints. Osteoarthritis Cartilage. 2016;24(11):1999\u20132002. https:\/\/doi.org\/10.1016\/j.joca.2016.07.007.","journal-title":"Osteoarthritis Cartilage"},{"key":"6526_CR26","first-page":"1022","volume":"3","author":"A Tnibar","year":"2017","unstructured":"Tnibar A, Britt Persson A, Elvang Jensen H. Mechanisms of action of an intraarticular 2.5% polyacrylamide hydrogel (Arthramid Vet) in a goat model of osteoarthritis: preliminary observations. SM J Biomed Eng. 2017;3:1022.","journal-title":"SM J Biomed Eng"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06526-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-06526-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06526-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T18:06:19Z","timestamp":1768845979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13018-025-06526-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6526"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-06526-0","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and subsequent amendments were approved by the local Health Research Ethics committee (reference number: H-19031685), the Danish Health Authorities, and registered at ClinicalTrials.gov (NCT04179552). The participants gave informed consent prior to participation and reconsent for participation in the extension. The study was conducted according to the principles of Good Clinical Practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HB and MH have received travelling grants from Contura International A\/S. HB has received consulting fees, honoraria, research or institutional support, educational grants, equipment, services or expenses from Abbott, Abbvie, Amgen, AstraZeneca, Aventis, Axellus, Bristol Myers Squibb, Cambridge Weight Plan, Contura, Dansk Droge, Eurovita, Ferrosan, GlaxoSmithKline, Hoechst, LEO, Eli Lilly, Lundbeck, MSD, Mundipharma, Norpharma, NOVO, NutriCare, Nycomed, Pfizer, Pharmacia, Pierre-Fabre, Proctor&Gamble, Rhone-Poulenc, Roche, Roussel, Schering-Plough, Searle, Serono, UCB, Wyeth. PGC has received consulting or speaker fees from AbbVie, Eli Lilly, Eupraxia, Formation Bio, Genascence, Grunenthal, Levicept, Medipost, Novartis, Pacira, Stryker and Takeda. MH has received consulting fees from the Thuasne Group and Leo Pharma and is associate editor of Osteoarthritis and Cartilage. JB and AH have reported no conflicts.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}